Bioinformatics prediction and experimental verification identify a cuproptosis-related gene signature as prognosis biomarkers of hepatocellular carcinoma

被引:0
|
作者
Wang, Weiwei [1 ]
He, Zhiguo [1 ]
Jia, Haowen [2 ]
Zhang, Jiansheng [1 ]
Qi, Feng [3 ]
机构
[1] Tianjin Med Univ, Baodi Clin Coll, Dept Gen Surg, 8 Guangchuan Rd, Tianjin 301800, Peoples R China
[2] Tianjin Med Univ Gen Hosp, Airport Hosp, Dept Gen Surg, Tianjin, Peoples R China
[3] Tianjin Med Univ Gen Hosp, Dept Gen Surg, 154 Anshan Rd, Tianjin 300052, Peoples R China
基金
中国国家自然科学基金;
关键词
Cuproptosi; gene signature; hepatocellular carcinoma (HCC); prognostic analysis; immune infiltration; PYRUVATE-DEHYDROGENASE COMPLEX; CELL-DEATH; COPPER DEFICIENCY; OXIDATIVE STRESS; CANCER; DISULFIRAM; INHIBITION; DRUG; MITOCHONDRIA; EXPRESSION;
D O I
10.21037/tcr-23-1561
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Hepatocellular carcinoma (HCC) of which its prognostic prediction is still unclarified is a highly heterogeneous disease. Cuproptosis is a form of cell death that depends on copper regulation. Whether the cuproptosis-related genes can be the prognostic indicators of HCC is yet to be elucidated. The aim of this study is to investigate whether cuproptosis-related genes play a role in HCC and can be used as a diagnostic index to predict the occurrence of liver cancer. Methods: We downloaded HCC patients' gene expression profiles and their corresponding clinical data from a public database. To screen data, we used single factor Cox regression analysis, meanwhile, polymerase chain reaction (PCR) was used for the verification. After that, the risk score was calculated and the relationship between risk score and clinical factors was analyzed. Besides, a nomogram map was constructed for predicting the prognosis of HCC, and calibration map and decision curve analysis (DCA) map were used to test the model. Results: Compared to the high expression group of four cuproptosis-related genes, the low expression group showed better overall survival (OS) [hazard ratio (HR) =2.58; 95% confidence interval (CI): 1.72-3.89, P<0.001]. The expression of the four cuproptosis-relate genes increased in liver cancer cell lines compared to liver cell lines (P<0.05). Based on these four genes, we calculated the risk score and divided them into two groups as high-risk group and low-risk group. The risk factor map showed the high-risk group had shorter survival time and the four genes were highly expressed. The area under curve (AUC) of receiver operating characteristic (ROC) prediction curve for the first year was 0.726. Risk scores were closely related to clinical factors and immune cells. Finally, we constructed a nomogram for predicting the prognosis of HCC. Conclusions: The risk score for cuproptosis-related genes was established and involved in the construction of the nomogram, providing a new perspective on the prognosis and copper metabolism of HCC.
引用
收藏
页码:2985 / 3002
页数:18
相关论文
共 50 条
  • [1] Bioinformatics prediction and experimental verification identify cuproptosis-related lncRNA as prognosis biomarkers of hepatocellular carcinoma
    Zhu, Liangyu
    Zhang, Bochao
    Yin, Guoquan
    Yuan, Zhang
    Heng, Li
    Zhou, Hanyu
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2023, 35
  • [2] Cuproptosis-related molecular classification and gene signature of hepatocellular carcinoma and experimental verification
    Chen, Zehao
    Du, Dongnian
    Li, Jiajuan
    Zhang, Wenming
    Shao, Jianghua
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (03) : 1268 - 1289
  • [3] Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
    Cong, Tianhao
    Luo, Yingen
    Liu, Yu
    Yang, Chao
    Yang, Hongcai
    Li, Yujie
    Li, Jingui
    Li, Xiao
    FRONTIERS IN GENETICS, 2022, 13
  • [4] Cuproptosis-related signature for clinical prognosis and immunotherapy sensitivity in hepatocellular carcinoma
    Shaohua Xu
    Kexin Dong
    Ruihuan Gao
    Ying Yang
    Yidan Zhou
    Chunhua Luo
    Wei Chen
    Song-Mei Liu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 12249 - 12263
  • [5] A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
    Zhang, Genhao
    Sun, Jianping
    Zhang, Xianwei
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
    Genhao Zhang
    Jianping Sun
    Xianwei Zhang
    Scientific Reports, 12
  • [7] Cuproptosis-related signature for clinical prognosis and immunotherapy sensitivity in hepatocellular carcinoma
    Xu, Shaohua
    Dong, Kexin
    Gao, Ruihuan
    Yang, Ying
    Zhou, Yidan
    Luo, Chunhua
    Chen, Wei
    Liu, Song-Mei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (13) : 12249 - 12263
  • [8] A novel cuproptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma
    Yang, Fan
    Jiang, Shitao
    Liu, Yaoge
    Zhang, Ting
    Zhu, Chengpei
    Zhang, Lei
    Sang, Xinting
    Lu, Xin
    Wei, Jiaxin
    Deng, Kaige
    Zheng, Yongchang
    Xu, Yiyao
    HELIYON, 2022, 8 (11)
  • [9] Bioinformatics Prediction and Experimental Validation Identify a Novel Cuproptosis-Related Gene Signature in Human Synovial Inflammation during Osteoarthritis Progression
    Wang, Wenjuan
    Chen, Ziyi
    Hua, Yinghui
    BIOMOLECULES, 2023, 13 (01)
  • [10] A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
    Wu, Jingyi
    Yao, Jianzuo
    Jia, Shu
    Yao, Xiaokun
    Shao, Jingping
    Cao, Weijuan
    Ma, Shuwei
    Yao, Xiaomin
    Li, Hong
    HELIYON, 2023, 9 (09)